SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001454982-09-000096
Filing Date
2009-06-10
Accepted
2009-06-10 18:30:39
Documents
2
Period of Report
2009-06-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 1462
2 EDGAR SUPPORTING DOCUMENT behrenspoa.txt EX-24 2117
  Complete submission text file 0001454982-09-000096.txt   5345
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Issuer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6701 KAISER DRIVE FREMONT CA 94555
Business Address
BEHRENS M KATHLEEN (Reporting) CIK: 0001211701 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19700 | Film No.: 09885640